Onzima Ventures Share Discussion Threads

[superg1] 17/10/2016 10:42

Not proven yet to work and I'm confused as to why they use Dermasys when it's theoretically not needed due to the location of use which doesn't have the same skin barriers.

GTN and simlar drugs are well known to dilate blood vessels it's all about the dalton weight for dermal penetration.

Enough of FUM talk, where are the ONZ fellas it's very quiet here considering the news. Not a pleasant event and I see share propehets did an article some time back suggesting N4 looked like it may mess up the policy and thus it seems it has.

Looking back it doesn't look right, £40k ish for half the company???. I can't get a running burger van for that

[mrphiljones] 17/10/2016 09:23

getting lead into ones pencil


;-)

[superg1] 17/10/2016 09:13

Why FUM?

I know that one well and they will need to do a new trial for MED at a higher dosage rate if you are talking MED I assume so due to the N$ link). So 1 to 2 years before they sort that out and no guarantee it will work.

[someuwin] 17/10/2016 08:53

The resource stuff is irrelevent. It's all about N4 Pharma.

Even if ONZ delists it is shouldn't matter. They still own 49% of N4.

When N4 does its IPO, ONZ shareholders will get a pro rata holding.

That's the theory anyway.

[mrphiljones] 17/10/2016 08:41

FUM?.....;-))

[fireball xl5] 17/10/2016 08:39

N4 is surely in the Natural Resource sector, isn't it about getting lead into ones pencil lol

[superg1] 17/10/2016 08:14

Isn't it the first paragraph where it falls down as all the talk here is about N4 pharma when the policy states resources sector.

The Company will seek to invest a minimum of 75 per cent. of its deployable capital in, and/or acquire companies or interests within, the natural resources sector - in which the new Directors have substantial experience as founders, investors and advisers.

Just trying to guess. I see they did a loan with N4 too which they can do but state were not going to at this time re loans.

The first thought is something to do with N4.

[flashheart] 17/10/2016 08:02

Any thoughts keya? Surely it must be easy enough to adapt their investing policy to satisfy requirements rather than facilitate an RTO at this stage? By what criteria have they failed on this?

[cufes2] 17/10/2016 07:45

Hmmm . . .

Investing Policy

Accordingly the Company has adopted the following Investing Policy:

The Company will seek to invest a minimum of 75 per cent. of its deployable capital in, and/or acquire companies or interests within, the natural resources sector - in which the new Directors have substantial experience as founders, investors and advisers.

The Company will participate as investors in fundraisings for entities being admitted to trading on AIM, in secondary fundraisings, or where such entities plan to be admitted to trading on an Exchange within 18 months of investment by the Company.

Investments are likely to be held for the short to medium term in the case of publicly-traded holdings and for the longer term in respect of private holdings until there is a liquidity event when the Company may seek to reduce its exposure. There will be no minimum or maximum limit on the length of time an investment is held.

Initially the geographical focus will be Africa and North America but investments may be considered in other regions to the extent that the Board considers that an opportunity exists where significant returns can be made.

The Company may also invest in assets, projects or joint ventures using equity or debt structures, gaining direct exposure. Investments will generally be made on a passive basis unless there is a requirement to provide management or other expertise to the investee entity in seeking to generate positive returns for the Company.

In selecting investment opportunities, the Board will focus on companies, assets and/or projects that it believes are available at attractive valuations and where there is an opportunity to benefit from value uplift. The Company's equity holdings or interests may range from a minority position to 100 per cent. ownership.

The Directors will conduct due diligence appraisals of potential investments, businesses or projects and, where they believe further diligence is required or warranted, intend to utilise appropriately qualified persons to assist. The Directors believe they have a network which is likely to provide various opportunities which may prove suitable.

The Company does not plan to have cross-holdings in entities save where there is a portfolio of related assets outside of the Company's control.

The Board considers that as investments are made, and new investment opportunities arise, further funding of the Company may also be required which is likely to be in the form of equity, until such time as the Company is self-funding.

It is intended that returns for Shareholders will initially be in the form of capital growth, subject to appreciation in the value of the investments made by the Company. In the longer term, if the Company becomes cash generative, then the plan will be to put in place an appropriate dividend policy as appropriate for a Company with its activities at that time.

The Company plans to have a maximum of fifteen investments / interests at any one time. Though there will be no maximum exposure to any one investment, it will generally seek to diversify its portfolio holdings. The Company's financial resources may ultimately be invested in a number of propositions or in just one investment, which may be deemed to be a reverse takeover pursuant to Rule 14 of the AIM Rules requiring shareholder approval.

The Company also intends to acquire over a period of time a diversified portfolio of royalties. These will consist, in varying proportions, of royalties over:

- producing properties purchased at a discount to perceived value; 16 - producing properties with enhanced production possibilities; and

- non-producing properties where advanced exploration is likely.

It is intended that over the longer term the royalty investments will provide cashflow to finance further investment opportunities, minimising dilution to Shareholders through reduced equity financing requirements.

The Company does not currently intend to fund any investments with debt or other borrowings but may do so if appropriate. The Board may also offer New Ordinary Shares in the capital of the Company by way of consideration as well as utilising cash, preserving the Company's cash for additional opportunities and working capital.

Following on from adopting an Investing Policy, the Company will be required to make an acquisition or acquisitions which constitute a reverse takeover under the AIM Rules or otherwise implement its Investing Policy within 12 months of the General Meeting, failing which the ordinary shares would then be suspended from trading on AIM. If the Investing Policy has not been implemented within 18 months of the General Meeting the admission to trading on AIM of the ordinary shares would be cancelled and the Directors will convene a general meeting of the Shareholders to consider whether to continue seeking investment opportunities or to wind up the Company and distribute any surplus cash back to Shareholders.

[superg1] 17/10/2016 07:42

Bloody AIM for you how can you forecast that they couldn't even sort out an investing policy. That explains the selling you guys saw by those in the know.

[curlly] 17/10/2016 07:38

Didn't see that one coming

[pennyfalls] 14/10/2016 18:30

bdog51 - this may be the best thing sliced bread, but maybe not..
If I had a quid for everytime someone has said what you've said about a penny share, I'd be rich..
whatever the potential, it's got to be realised and this is high risk...this is still "potential" and not reality.
I don't know how long you've been on AIM, but those in the know, get to seell/buy first - all it takes is a delay in Pharma, or one knockback - and this will hit the dirt..
Conversely , it will it hit the heavens if it goes out way..

But to pre-suppose anything on this market is foolis,h to say the least

[bdog51] 14/10/2016 16:36

Don't understand why anyone would sell at these lows, after all the MCAP is ridiculously low. So much upside potential with the next news, which can't be far off now.

[keya5000] 12/10/2016 08:52

Seems to have consolidated at the bottom of the channel again.

[luminoso] 10/10/2016 20:40

I think I would welcome that, keya. A bit more focus and less scattergun needed.

[keya5000] 10/10/2016 14:19

Yes about time.

News is due on the 'investment status' being completed and the new investment which is likely a pharma one, possible RTO of N4 in full.

[bdog51] 10/10/2016 14:11

Good to see some blue returning here. News awaited...

[someuwin] 10/10/2016 14:04

Ticking up a bit now.

[tidy 2] 30/9/2016 14:03

Another deal imminent guys

[keya5000] 30/9/2016 13:47

good news, must be another pharma purchase or more into N4?

[keya5000] 23/9/2016 16:20

Agree, unloved but only for a while I suspect.